levels,79-81 but a meta-analysis of 45 studies of hypercholesterolemic patents did not indicate an increased
risk of stroke.
Nonetheless, there is compelling evidence that
decreasing low-density lipoprotein (LDL) levels through
lipid-lowering therapy is highly effective in decreasing
stroke risk among patients with known atherosclerotic
disease. A meta-analysis of 28 randomized clinical trials
including more than 10